---
layout: default
title: Antimony Trisulfide Bos Taurus Hypothalamus Fucus 
parent: 僅模型預測 (L5)
nav_order: 329
evidence_level: L5
indication_count: 0
---

# Antimony Trisulfide Bos Taurus Hypothalamus Fucus 
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Multi-Ingredient Compound (Antimony Trisulfide / Fucus Vesiculosus / Thyroid): Insufficient Evidence for Repurposing Evaluation

## One-Sentence Summary

This is a complex multi-ingredient preparation comprising seven components — including homeopathic minerals, bovine glandulars, botanical extracts, and a thyroid fraction — with no established approved indication on record.
The TxGNN model was **unable to generate any repurposing prediction** for this compound, most likely because the multi-ingredient composition could not be mapped to a single DrugBank entity.
As a result, **no clinical trial or literature evidence** can be linked to a predicted new indication at this time.

---

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | None on record |
| Predicted New Indication | None (TxGNN prediction not available) |
| TxGNN Prediction Score | N/A |
| Evidence Level | L5 — model prediction unavailable; no supporting studies |
| US Market Status | Not marketed |
| Number of NDAs | 0 |
| Recommended Decision | Hold |

---

## Why is This Prediction Reasonable?

Detailed mechanism of action data is not available, and no DrugBank ID could be assigned to this compound. The seven ingredients span multiple pharmacological categories:

- **Fucus vesiculosus** (bladderwrack) contains iodine and has historically been associated with thyroid modulation.
- **Thyroid, unspecified** is a crude glandular extract sometimes used in traditional compounding.
- **Phytolacca americana root** carries immune-modulatory and anti-inflammatory properties in herbal medicine literature, but its clinical evidence base is sparse.
- **Semecarpus anacardium juice** is an Ayurvedic botanical with reported anti-tumour and anti-inflammatory activity in preclinical models.
- **Antimony trisulfide** and **sodium sulfate** are inorganic compounds with roots in homeopathic practice.
- **Bos taurus hypothalamus** is a bovine glandular used in integrative medicine formulations.

Because the compound is a mixture of chemically and pharmacologically heterogeneous agents, the TxGNN knowledge-graph model — which operates on single-entity DrugBank nodes — cannot assign a unified drug representation and therefore produces no prediction. Without a prediction, there is no anchor disease to evaluate.

---

## Clinical Trial Evidence

Currently no related clinical trials registered.

---

## Literature Evidence

Currently no related literature available for the compound as a whole. Individual ingredients have scattered preclinical reports, but these cannot be attributed to this multi-ingredient formulation as a unit.

---

## US Market Information

This compound holds no NDA or any US market authorization. No product licensing records were retrieved.

---

## Safety Considerations

Please refer to the package insert for safety information.

For individual ingredient safety considerations:
- **Phytolacca americana (pokeweed)** is recognized as toxic in high doses; roots contain phytolaccatoxin and phytolaccigenin.
- **Semecarpus anacardium** juice contains urushiol-type compounds and may cause contact sensitization.
- Thyroid glandular extracts carry risk of hyperthyroidism in sensitive patients.

No formal drug–drug interaction data is available for this combination.

---

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The compound cannot be processed by the TxGNN repurposing pipeline because it lacks a DrugBank identifier and comprises seven pharmacologically disparate ingredients. Without a prediction, there is no candidate indication to evaluate, and no safety dossier exists to support a go/no-go assessment.

**To proceed, the following is needed:**

- Clarify whether this is a **registered homeopathic or naturopathic product** — if so, retrieve the official product monograph and indication text from the originating regulatory body (e.g., FDA OTC homeopathic monograph, DSHEA supplement filing)
- Decompose the formulation into **individual active ingredients** and run TxGNN predictions separately for each mappable component (e.g., Fucus vesiculosus, Phytolacca americana)
- Obtain a **DrugBank ID or equivalent ontology identifier** for at least the botanically or pharmacologically dominant component to enable knowledge-graph traversal
- Conduct a **safety review** for each ingredient individually, with particular attention to pokeweed toxicity thresholds and iodine-induced thyroid effects
- Assess whether this compound meets the threshold for **drug vs. dietary supplement classification** before investing further repurposing resources
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

